Skip to content

Efficacy of fibrin sealant in reducing resection surface crelated complications after partial liver resections

Efficacy of fibrin sealant in reducing resection surface crelated complications after partial liver resections (FRESCO trial): A Dutch, multicentre, prospective, randomised, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN85205641
Enrollment
600
Registered
2010-05-28
Start date
2006-05-23
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Partial liver resection complications Surgery Liver resection

Interventions

Randomisation to treatment group will be performed using a sealed envelope and will be performed prior to peritoneal closure after completion of conventional hemostasis and bile stasis. Only the surg

Sponsors

Johnson and Johnson Medical Limited (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged greater than or equal to 18 years, either sex 2. Undergo liver resections (at least one segment) for benign or malignant tumours or metastatic tumours, or 3. Undergo liver resection in combination with radiofrequency ablation (RFA)

Exclusion criteria

Exclusion criteria: 1. Aged less than 18 years 2. Undergo liver resections with extrahepatic biliary resection and reconstruction (Klatskin tumours) 3. Cirrhosis 4. Other disorders of haemostasis 5. Polycystic liver disease 6. Any associated operative gastrointestinal procedures (a needle catheter jejunostomy is not excluded) 7. Wedge resections 8. Pregnancy 9. History of hypersensitivity, allergy or anaphylactic reaction to any plasma derived product, including fibrin sealant

Design outcomes

Primary

MeasureTime frame
1. Resection surface related complications detected by computed tomography (CT) scan or clinical symptoms: haematoma, biloma or subphrenic abscess 2. Diaphragm related complications detected by CT scan or clinical symptoms: pleural effusion 3. Need for reintervention for bleeding or bile leakage from the cut surface of the liver, or pleural effusion CT scan after 7 days, further assessment of complications and reinterventions during hospital stay until first out-patient appointment.

Secondary

MeasureTime frame
1. Changes in drain bilirubin (micromol/l), drain hemoglobin concentration (mmol/l) and volume of fluid drainage (ml) from the abdominal drains during the first three days post-operatively 2. Decrease in serum haemoglobin concentration (mmol/l) (lab day 1, 3, 5, 7, thereafter weekly) 3. Transfusion requirement (whole admission until first outpatient appointment) 4. Post-operative morbidity (whole admission until outpatient appointment) 5. Post-operative mortality (whole admission until outpatient appointment) 6. Length of hospital stay (whole admission until outpatient appointment)

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 25, 2026